pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Ovid Therapeutics Inc. ($OVID) · news · pharmadog
← back to Ovid Therapeutics Inc.
News mentioning $OVID
10
stories
8d
China has a clear shot to 2030 goals, though economic, cultural barriers remain
biospace
8d
Without US action on China’s innovation blitz, biotech leaders see a Rust Belt future
biospace
16d
UniQure gets an FDA decision date; Teva scraps brain drug study
biopharma dive
Oct 19, 26
China tightens grip on biotech platform ownership but foreign licensing deals still okay
biospace
Oct 15, 26
Webinar: The China question: Can US biotechs lead as investment heads east?
biospace
Sep 23, 26
China’s surging biotech sector represents both competition and lifeline for the US
biospace
Sep 15, 26
Rare disease reform, CMC risk, reshoring US trials top of mind ahead of PDUFA VIII meeting
biospace
Sep 10, 26
For PDUFA VIII, the most valuable incentive may be time
biospace
Aug 13, 26
Ovid and Takeda's epilepsy drug gets new life at Perceptive-backed NewCo
endpoints
May 13, 26
FDA’s leadership void leaves biotech with renewed ‘uncertainty’
biopharma dive